Related Experiment Video
Updated: Jun 22, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemia
Runkuan Yang1, Keita Miki, Niku Oksala
1Dept. of Critical Care Medicine, Univ. of Pittsburgh Medical School, 1055 Scaife Hall, 3550 Terrace St., Pittsburgh, PA 15261, USA. yangr@ccm.upmc.edu
Lipopolysaccharide (LPS) causes gut barrier dysfunction in sepsis. Bile containing high-mobility group box 1 (HMGB1) released by macrophages contributes to this dysfunction, which can be reversed by blocking HMGB1.
Area of Science:
- Gastroenterology
- Immunology
- Sepsis Pathophysiology
Background:
- Lipopolysaccharide (LPS) is a key factor in sepsis, known to induce intestinal hyperpermeability and bacterial translocation.
- LPS stimulates Kupffer cells to release TNF-alpha into bile, suggesting bile plays a role in endotoxemia.
Purpose of the Study:
- To investigate if hepatic Kupffer cells and macrophages release high-mobility group box 1 (HMGB1) into bile following LPS stimulation.
- To determine if bile containing HMGB1 contributes to gut barrier dysfunction in experimental endotoxemia.
Main Methods:
- Rats underwent bile duct catheterization and LPS administration, with bile flow and cytokine levels monitored.
- Neutralizing anti-HMGB1 antibody or sham IgG was administered into the duodenal lumen of endotoxemic rats.
- Normal mice were gavaged with normal or endotoxemic rat bile to assess its effects on gut barrier function.
Main Results:
- LPS challenge significantly decreased bile flow rate and increased bile TNF-alpha and HMGB1 levels.
- Anti-HMGB1 antibody administration reversed LPS-induced gut barrier dysfunction in rats.
- Endotoxemic rat bile increased gut mucosal permeability and bacterial translocation in normal mice, effects reversible by HMGB1 removal.
Conclusions:
- Bile HMGB1 is significantly elevated in experimental endotoxemia.
- Bile HMGB1 mediates gut barrier dysfunction, increasing intestinal permeability and bacterial translocation.
- Targeting bile HMGB1 represents a potential therapeutic strategy for sepsis-induced gut injury.
Related Concept Videos
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Gut-Brain Axis
